Access to diagnosis and treatment of patients with suspected sleep apnea
Access to diagnosis and treatment of patients with suspected sleep apnea
复制标题
DOI:
10.1164/rccm.200308-1124pp
复制
发表时间:
2004-03-15
影响因子:
24.7
通讯作者:
Wheatley, J
中科院分区:
文献类型:
--
作者:
Flemons, WW;Douglas, NJ;Wheatley, J
BACKGROUNDBrief periods of breathing cessation (apneas) or marked reduction in V t (hypopneas) are common in adults during sleep. Prospective studies indicate that sleep apnea contributes to systemic hypertension (1), is a modifiable risk factor for motor vehicle accidents (2), and that its adverse impact on quality of life is treatable (3–6). As a result, there is substantial and growing demand by patients to access diagnostic studies and effective treatment. Wait times result when demand exceeds capacity. Demand is influenced by (1) prevalence and incidence of sleep apnea,(2) cost and patient reimbursement policies,(3) patient and primary physician awareness, and (4) wait times. Capacity is dictated by (1) availability of sleep laboratory beds determined by funding policies,(2) adherence to guidelines for diagnosing sleep apnea and continuous positive airway pressure (CPAP) titration published by the American Academy of Sleep Medicine (7) and the American Thoracic Society (8),(3) availability of sleep specialists, and,(4) policies about who can order/interpret diagnostic polysomnography and CPAP titration studies. This article represents information from five countries regarding their population, annual number of sleep studies performed, the range of wait times patients experience, and some strategies used for dealing with the mismatch between demand and capacity (Table 1)